title: [Total laparoscopic hysterectomy. Operative technique, results and indications].
abstract: Total hysterectomy was performed via laparoscopy alone in 50 patients. In all cases, the operation was carried out using conventional, re-usable instruments (grasping forceps, laparoscopic scissors, bipolar coagulation). The mean duration of the operation was 163 min (range: 110-270 min). The mean drop in haemoglobin was 1.97 g/100 ml (range: 0-4 g/100 ml) and the average length of hospital stay was 3.9 days (range: 2-13 days). In one case (2%), we converted to laparotomy because a lateral myoma made it impossible to achieve haemostasis of the uterine pedicule under suitably safe conditions. No serious peri or post-operative complications were encountered. No second surgery was necessary and no transfusion was required. These results confirm that total laparoscopic hysterectomy via laparoscopy is a safe, feasable and reproductible technique. Future work will establish the exact place and methods for laparoscopic surgery for hysterectomy. Laparoscopic surgery is only indicated when vaginal hysterectomy is contraindicated or impossible. Laparoscopic hysterectomy constitutes an alternative to laparotomy rather than the vaginal hysterectomy. The combination of an immobile uterus and poor vaginal accessibility is the prime indication for total hysterectomy via laparotomy.
authors.affiliation: Service de Chirurgie Gynécologique, Clinique Universitaire Baudeloque, C.H.U. Cochin-Port-Royal, Paris.
authors.forename: C
authors.initials: C
authors.lastname: Chapron
authors.forename: J B
authors.initials: JB
authors.lastname: Dubuisson
authors.forename: V
authors.initials: V
authors.lastname: Aubert
authors.forename: P
authors.initials: P
authors.lastname: Morice
authors.forename: P
authors.initials: P
authors.lastname: Garnier
authors.forename: F X
authors.initials: FX
authors.lastname: Aubriot
authors.forename: H
authors.initials: H
authors.lastname: Foulot
mesh_terms: D000328:Adult; D000368:Aged; D016063:Blood Loss, Surgical; D005240:Feasibility Studies; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D007044:Hysterectomy / Q000009:adverse effects / Q000295:instrumentation / Q000379:methods*; D020706:Laparoscopes; D010535:Laparoscopy / Q000009:adverse effects / Q000379:methods*; D007902:Length of Stay; D008875:Middle Aged; D018579:Patient Selection; D013997:Time Factors